Clinical Trials at Memorial Sloan Kettering Bergen (Limited Protocol Activities)
As of July 2026, 109 paid clinical trials are recruiting at Memorial Sloan Kettering Bergen (Limited Protocol Activities), located at 225 SUMMIT AVE, MONTVALE, NJ 07645-1523, phone (212) 639-2000 in Montvale, New Jersey. Active studies at this site cover conditions such as Breast Cancer, Acute Myeloid Leukemia and Multiple Myeloma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Montvale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
112 clinical trials at Memorial Sloan Kettering Bergen (Limited Protocol Activities)
·Clear filters·↓ Download CSVA Study of Mirdametinib in People With Central Nervous System Tumors
A Study of Ivonescimab in People With Leiomyosarcoma
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer
Factors Associated With Breast Cancer Risks and Outcomes
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
A Study of 177Lu-PSMA-617 in People With Gliomas
A Dietary Study for People With Multiple Myeloma
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol
A Study of Tarlatamab for People With Prostate Cancer
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
A Registry for People With Lung Cancer
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
A Study of Hospital-at-Home for People Receiving Tarlatamab
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
Study of Aerobic Training for People Receiving Treatment for Breast Cancer
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
About research studies in Montvale
Montvale has approximately 304 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Common conditions studied in Montvale
- Breast Cancer (28 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Acute Myeloid Leukemia (12 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Multiple Myeloma (12 active studies). Recruiting Multiple Myeloma studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Non-Small Cell Lung Cancer (10 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Prostate Cancer (10 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Metastatic Breast Cancer (9 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
Leading research sponsors in Montvale
- Memorial Sloan Kettering Cancer Center
- National Cancer Institute (NCI)
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- Pfizer
Local regulations and guidelines
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Montvale. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Montvale
Hipa.ai aggregates every recruiting study in Montvale from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Montvale?
There are approximately 304 recruiting clinical trials in Montvale, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Montvale pay participants?
Most recruiting trials in Montvale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Montvale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Montvale?
The most common conditions under active study in Montvale include Breast Cancer (28), Acute Myeloid Leukemia (12), Multiple Myeloma (12), Non-Small Cell Lung Cancer (10), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Montvale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Montvale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Montvale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Montvale?
Recruiting research sites in Montvale include Memorial Sloan Kettering Bergen (Limited Protocol Activities), Memorial Sloan Kettering Bergen, Memorial Sloan Kettering Bergen (All Protocol Activities), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Montvale right now?
The largest active categories in Montvale are Cancer & tumors (249), Neurology & pain (2), HIV / STI (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Memorial Sloan Kettering Bergen (Limited Protocol Activities)?
Memorial Sloan Kettering Bergen (Limited Protocol Activities) is located at 225 SUMMIT AVE, MONTVALE, NJ 07645-1523. Use the Google Maps link in the intro above to get directions.
How do I contact Memorial Sloan Kettering Bergen (Limited Protocol Activities)?
You can reach Memorial Sloan Kettering Bergen (Limited Protocol Activities) by phone at (212) 639-2000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.